Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene
- PMID: 8861914
- DOI: 10.1016/s0092-8674(00)81348-3
Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene
Abstract
Interferon consensus sequence binding protein (ICSBP) is a transcription factor of the interferon (IFN) regulatory factor (IRF) family. Mice with a null mutation of ICSBP exhibit two prominent phenotypes related to previously described activities of the IRF family. The first is enhanced susceptibility to virus infections associated with impaired production of IFN(gamma). The second is deregulated hematopoiesis in both ICSBP-/- and ICSBP+/- mice that manifests as a syndrome similar to human chronic myelogenous leukemia. The chronic period of the disease progresses to a fatal blast crisis characterized by a clonal expansion of undifferentiated cells. Normal mice injected with cells from mice in blast crisis developed acute leukemia within 6 weeks of transfer. These results suggest a novel role for ICSBP in regulating the proliferation and differentiation of hematopoietic progenitor cells.
Similar articles
-
Expression of interferon consensus sequence binding protein (ICSBP) is downregulated in Bcr-Abl-induced murine chronic myelogenous leukemia-like disease, and forced coexpression of ICSBP inhibits Bcr-Abl-induced myeloproliferative disorder.Mol Cell Biol. 2000 Feb;20(4):1149-61. doi: 10.1128/MCB.20.4.1149-1161.2000. Mol Cell Biol. 2000. PMID: 10648600 Free PMC article.
-
Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression.J Exp Med. 1997 Nov 3;186(9):1535-46. doi: 10.1084/jem.186.9.1535. J Exp Med. 1997. PMID: 9348311 Free PMC article.
-
Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias.Blood. 1998 Jan 1;91(1):22-9. Blood. 1998. PMID: 9414265
-
ICSBP/IRF-8: its regulatory roles in the development of myeloid cells.J Interferon Cytokine Res. 2002 Jan;22(1):145-52. doi: 10.1089/107999002753452755. J Interferon Cytokine Res. 2002. PMID: 11846985 Review.
-
[Interferon].Gan To Kagaku Ryoho. 1997 Sep;24(11):1471-6. Gan To Kagaku Ryoho. 1997. PMID: 9309144 Review. Japanese.
Cited by
-
Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity.Front Immunol. 2020 Aug 27;11:1963. doi: 10.3389/fimmu.2020.01963. eCollection 2020. Front Immunol. 2020. PMID: 32983128 Free PMC article. Review.
-
Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.Am J Hum Genet. 2016 Jul 7;99(1):22-39. doi: 10.1016/j.ajhg.2016.05.003. Epub 2016 Jun 23. Am J Hum Genet. 2016. PMID: 27346689 Free PMC article.
-
Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization.Nat Immunol. 2012 May 20;13(7):642-50. doi: 10.1038/ni.2304. Nat Immunol. 2012. PMID: 22610140 Free PMC article.
-
Bcr-abl regulates Stat5 through Shp2, the interferon consensus sequence binding protein (Icsbp/Irf8), growth arrest specific 2 (Gas2) and calpain.Oncotarget. 2016 Nov 22;7(47):77635-77650. doi: 10.18632/oncotarget.12749. Oncotarget. 2016. PMID: 27769062 Free PMC article.
-
Single-cell analysis of mixed-lineage states leading to a binary cell fate choice.Nature. 2016 Sep 29;537(7622):698-702. doi: 10.1038/nature19348. Epub 2016 Aug 31. Nature. 2016. PMID: 27580035 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials